A Study Comparing Two Formulations of Selpercatinib (LY3527723) in Healthy Participants
Clinical trial NCT05089019 · COMPLETED
Trial details
- NCT number
- NCT05089019
- Sponsor
- Loxo Oncology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-29
- Primary completion
- 2022-07-19
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.